Barely Significant
← all excerpts

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers.

Ann Oncol · 2019 · PMC6594459 · PMID 30895304

Europe PMCDOI
3
hedged sentences
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

a trend toward significanceP = 0.05actually significant
Despite these results, a trend toward significance is shown in nodal metastases (0.64 AUC, P = 0.05) (see Figure 3 A).

also in 3,729 other papers

borderline significantP = 0.05actually significant
Results The biomarker reached significant performance on NSCLC lesions (up to 0.83 AUC, P < 0.001) and borderline significant for melanoma lymph nodes (0.64 AUC, P = 0.05).

also in 11,409 other papers

highly significantno p-value reported
We found highly significant associations with pathways involved in mitosis, indicating a relationship between increased proliferative potential and preferential response to immunotherapy.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.